Piperidine

Piperidine

SCHEMBL28040221

B.C1CCNCC1.c1ccncc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CHRNB2 P17787 4/20 0.38
CHRNA4 P43681 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.33
CXCR4 P61073 1/20 0.33
ADRB2 P07550 1/20 0.32
NCF1 P14598 1/20 0.32
PLD1 Q13393 1/20 0.32
MEN1 O00255 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C19 P33261 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
CHRNA7 P36544 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL27535943 1.00 ALDH1A1 (0.47) ALDH1A1TSHRNAPRTTDP1CHRNB2
Piperidine SCHEMBL8000110 0.97 ALDH1A1 (0.45) ALDH1A1TSHRNAPRTTDP1CHRNB2
Piperidine SCHEMBL2420379 0.97 ALDH1A1 (0.50) ALDH1A1TSHRNAPRTTDP1CHRNB2
Pyridine SCHEMBL812392 0.95 TSHR (0.53) ALDH1A1TSHRNAPRTTDP1CHRNB2
Pyridine SCHEMBL28057559 0.92 TSHR (0.50) ALDH1A1TSHRNAPRTTDP1CHRNB2
Pyridine SCHEMBL21497058 0.89 TSHR (0.60) ALDH1A1TSHRNAPRTTDP1CHRNB2
Pyridine SCHEMBL8406615 0.86 CXCR4 (0.50) ALDH1A1TSHRNAPRTTDP1CHRNB2
Pyridine SCHEMBL5210014 0.86 CXCR4 (0.50) ALDH1A1TSHRNAPRTTDP1CHRNB2
Pyridine SCHEMBL11825162 0.86
Piperidine SCHEMBL28471842 0.84 ALDH1A1 (0.38) ALDH1A1TSHRNAPRTTDP1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110403939-A For treating the tricyclic nitrogenous compound of N. gonorrhoeae infections GLAXOSMITHKLINE INTELECTUAL PROPERTY DEV LTD 2019-11-05 CN disclosed
CN-106659717-B Tricyclic nitrogen-containing compounds for the treatment of neisseria gonorrhoeae infections 葛兰素史密斯克莱知识产权发展有限公司 2019-09-06 CN disclosed
CN-105209443-B Indoleamine 2, 3-dioxygenase (IDO) inhibitors 百时美施贵宝公司 2018-08-07 CN disclosed
CN-107027306-A 1 (ring penta 2 base of alkene 1) 3 (2 hydroxyl 3 (aryl sulfonyl) phenyl) urea derivatives are used as CXCR2 inhibitor 葛兰素史密斯克莱知识产权发展有限公司 2017-08-08 CN disclosed
CN-106659717-A Tricyclic nitrogen-containing compounds for the treatment of neisseria gonorrhoeae infections 葛兰素史密斯克莱知识产权发展有限公司 2017-05-10 CN disclosed
CN-105517993-A Aryl amide kinase inhibitors BRISTOL MYERS SQUIBB CO 2016-04-20 CN disclosed
CN-105492444-A Tricyclic pyridine-carboxamide derivatives as ROCK inhibitors BRISTOL MYERS SQUIBB CO 2016-04-13 CN disclosed
CN-105209443-A Indoleamine 2, 3-dioxygenase (IDO) inhibitors BRISTOL MYERS SQUIBB CO 2015-12-30 CN disclosed